|
| |
|
The War on Legal Drugs: Follow The Money |
|
|
The US is the only industrialized country that doesn’t regulate the price of prescription drugs. |
|
|
LAHORE - 3 people lost their lives due to the suspected drug reaction that pushed the death toll to 109 on Saturday. (Pakistan Today) MORE: Toxic drugs and 'research tax' Faulty drugs
Studies gloss over side-effects OTTAWA - A Canadian researcher who surveys medical studies has found they consistently under-report possible side-effects of the drugs they test. (PostMedia) MORE: Why does Pharma bury half of its studies BMJ study CT scans produce widely differing radiation doses
ST. CATHARINES - The deaths - one Tuesday and the other in April - bring the number of deaths in Niagara from C. difficile to 28 since an outbreak was declared in St. Catharines May 28. (QMI) PREVIOUS: Hospitals are bad for your health Ontario to take over Niagara health system
WASHINGTON - The Supreme Court gave the pharmaceutical industry a pair of victories, shielding the makers of generic drugs from most lawsuits by injured patients and declaring that drug makers have a free-speech right to buy private prescription records to boost their sales pitches to doctors. (LA Times) JUDGMENT: SCOTUS 10-779 .pdf SCOTUS 09-993 .pdf
TORONTO - The Ontario government is sending auditors into pharmacies and generic drug manufacturers to make sure they're complying with new rules banning so-called professional allowances. (CP)
TORONTO - With 6 out of 10 provinces on pace to spend half of all available revenues on health care within six years, the current method of funding Canada’s health care system is not sustainable. (Fraser Institute) REPORT: Canada's Medicare Bubble .pdf 'Ethical bankruptcy' of health-care system
Lost in red tape after the headlines OTTAWA - A $139M project to fight HIV-AIDS, launched by Prime Minister Stephen Harper in a glitzy photo-op with Microsoft's Bill Gates, began to flounder within months, says an internal report. (CBC) PREVIOUS: After the headlines G8 summit in Gleneagles Analyses of aid Canadian HIV Vaccine Initiative
WINDSOR - A woman who was admitted to the Southwestern Regional Centre near Chatham, Ont., in 1971 is seeking to sue the provincial government for $2B over alleged abuse. (CBC)
VANCOUVER - The daughter of an elderly dementia patient is revealing how her mother was given a potentially dangerous drug - unapproved for treating her condition - in BC care facilities. (CBC)
PARIS - French politicians of both the right and left are facing severe embarrassment and legal recriminations with the forthcoming publication of an official report on what could become the worst health scandal in the country's history. (Independent UK) Mediator
Arthritis supplements don't work LONDON - European researchers analyzed the results of 10 past trials in 3,803 patients who took glucosamine, chondroitin or a placebo to treat arthritis in their hips or knees. (AP)
Health care has been good for us WASHINGTON - The top executives at the nation's five largest for-profit health insurance companies pulled in nearly $200M in compensation last year - while their businesses prepared to hit ratepayers with double-digit premium increases, according to a new analysis conducted by healthcare activists. (LA Times)
WASHINGTON - An undercover investigation by the Government Accountability Office found that four genetic testing companies delivered contradictory predictions based on the same person's DNA. Investigators also found that test results often contradicted patients' actual medical histories. (AP)
SALEM - A meth user can't make methamphetamine without pseudoephedrine, the main ingredient in most over-the-counter cold medicines like Sudafed, so first Oregon and now Missouri and Mississippi have made those medicines available only with a prescription. Companies such as Johnson & Johnson, Pfizer and Merck say it is too hard for customers to buy cold medicine. (ABC)
Poli-Grip linked to nerve damage The maker of Poli-Grip is warning users who have been heavily applying the denture adhesive for several years that they should stop using the product immediately. (CTV) MORE: Zinc in denture creams health risk
Canada needs a national strategy to prepare for a tidal wave of dementia cases in the coming decades that could swamp the health-care system and put a severe drain on the economy, a new report says. (Toronto Star) REPORT: Rising tide Dementia surge to cost $153B by 2038 Alzheimer's disease Too late for the current generation of politicians
The public are being warned of the dangers of buying unlicensed medicines on the internet. The alert comes as hundreds of websites are being shut down for selling fake or illicit drugs around the world. (Times online) MORE: Police warn of counterfeit drugs RCMP, CBSA join effort Web drugs overwhelmingly fake FDA issues warning letters Internet sting |
PRINCE GEORGE - For the second time in a week RCMP in Prince George, BC, have busted a pair of senior citizens on drug trafficking charges. It's the second time in less than a week that a pair of seniors have been arrested for trafficking prescription drugs. (CBC)
Lundbeck will demand that US distributors sign an agreement stating that they will not make pentobarbital, which is a sedative with a wide range of uses, available for prisons using it for lethal injections. The move comes after the UK banned the export to the US of pentobarbital and two other pharmaceutical drugs used to execute prisoners on death row. (Guardian UK) PREVIOUS: Assisted suicide
VANCOUVER - The BC Supreme Court has certified a class-action lawsuit on behalf of women who developed breast cancer after taking hormone replacement therapy. (QMI) RELATED: Treatment linked to cancer
OTTAWA - A “culture of secrecy” at Health Canada is preventing Canadians from getting important information about drug approval processes and health outcomes - an approach that could be putting patient safety at risk, doctors and policy experts charge. (Toronto Star) PREVIOUS: Public health care has no claim to moral superiority
Trade pact to add billions to bill A major new trade accord between Canada and the EU will add nearly $3B to the annual prescription drug bill here, according to a new report. (Canoe) MORE: Trade pact could cost billions
Researcher slams clinical trials They provide the best evidence possible of whether a drug or other medical intervention works and is safe, but clinical trials are being seriously hindered by regulations that push up costs, consume valuable time and do little to make the studies better, a prominent Canadian researcher argues in toughly worded new commentary. (National Post) PREVIOUS: Dangerous drugs, part 1 Dangerous drugs, part 2 Authorities were warned of killer weight loss drug
Shortages of a variety of prescription medications across Canada have left doctors and pharmacists scrambling to find replacement drugs, and forced many patients to switch from treatments they had used successfully for years, health professionals say. (National Post) MORE: Universal phamacare could save billions Generic firms push back
Drug use by drivers is nearly as common as alcohol use, new Canadian research suggests. A study of more than 14,000 driver fatalities in the country from 2000 to 2006 by the Canadian Centre for Substance Abuse found 33% of drivers tested positive for at least one drug and 38% tested positive for alcohol. (CBC)
'Scientific and ethical problems' More than a third of the published trials performed under 1997 legislation called the Pediatric Exclusivity Provision were carried out at least partly in developing or transitioning nations, such as Uganda and India, researchers found. (Reuters) REPORT: Globalization of Pediatric Research
GlaxoSmithKline, the maker of controversial diabetes drug Avandia knew 11 years ago that the medication increased risks of heart problems in patients but covered up that fact from the public, according to a Senate Finance Committee. (Fox)
TORONTO - A study group report released by the International Society for Stem Cell Research aims to educate those who might be tempted, by providing criteria for people to evaluate claims made by hundreds of these so-called "rogue" clinics around the world. The website http://www.closerlookatstemcells.org provides guidance on which illnesses or injuries are amenable to stem cell therapy. (CP)
Entitled get preferred treatment Politicians and top bureaucrats from provinces across the country have better access to cancer drugs and treatment than their constituents, according to Cancer Advocacy Coalition Canada. (QMI) Report card on cancer in Canada .pdf
TORONTO - Canadians are not able to quickly access newly developed prescription medicines because of the slow drug approval process and delays by provincial drug plans in approving the medicines for reimbursement, according to a new study released by a leading Canadian think-tank. (CanWest) REPORT: Access delayed, access denied 7 legal drugs that can kill kids in a single pill Legal highs
NEW YORK - New York, California and 13 other states are accusing biotech giant Amgen Inc. of offering kickbacks to medical providers to boost sales across the country of its anemia drug Aranesp, which increasingly has been beset by safety concerns. (LA Times) MORE: NY AG statement
NEW YORK - Across the US, pharmaceutical companies have been pleading guilty to criminal charges or paying penalties in civil cases when the US Department of Justice finds that they deceptively marketed drugs for unapproved uses, putting millions of people at risk of chest infections, heart attacks, suicidal impulses or death. Since May 2004, Pfizer, Eli Lilly & Co, Bristol-Myers Squibb and four other drug companies have paid a total of $7B in fines and penalties. (Bloomberg) |
|
Doctors refuse to authorize use A decade after Canada legalized the medical use of marijuana, most doctors are still refusing to sign the declarations patients need to get legal access to pot - meaning patients in pain risk being jailed if they use a drug that helps them function. (PostMedia) |
|
|
WASHINGTON - The battle over healthcare entered a new, more frenzied stage Wednesday, as lawmakers and powerful interest groups jockeyed for advantage now that most believe some form of an overhaul will ultimately be signed into law. The Senate Finance Committee's Tuesday passed a sweeping healthcare bill. Passage of a major bill by the House also is considered increasingly likely. But that success has spawned a furious scramble among insurers, labor unions and others to protect their interests in the weeks before the House and Senate begin voting on their final healthcare bills. Now, any financial gain by one group will likely correspond with losses by the others. (LA Times) |
Consumer protections lost in care debate Gutless politicians can't handle the truth Lobbyist’s gets a seat at trough Health care debate shifts to Main Street Canadian health system is broken A reality check on a reality check Pushing for US health care reform Big money fuels health care battle Health spending 2008 .pdf |
|
OTTAWA - Health Canada is being too secretive with information gathered about drugs and medical devices through clinical trials, an article published Monday in the Canadian Medical Association Journal states. (QMI) |
Unlocking cache of trade secrets Specialists, acute care greater threat Healthy eating is a privilege of the rich Edmonton Obesity Staging System |
|
Doctors have long extolled the flu shot's importance, prompting many to wince through the needle every year. But a new analysis has cast doubt on the effectiveness of that annual ritual. (CTV) Effectiveness of influenza vaccine Efforts to beat malaria may backfire Malaria deaths hugely underestimated Nationally representative mortality survey WHO denies exaggerating threat Canada donates 5M doses of vaccine Ottawa ponders H1N1 vaccine surplus EU to investigate WHO and 'pandemic' France sells off surplus vaccine How vaccines became big business The ties that bind apparent in Research Health bosses accused of flu-mongering |
WHO experts linked to drug companies WHO advisors had links to drug companies H1N1 overplayed by media, public health Provinces try to reduce vaccine lineups Death toll predictions slashed 20,000 seasonal flu deaths in UK MD group defends $500 per hour 'A whole industry is waiting for a pandemic' Feds blasted over single supplier Africa Malaria day- action or bombast? |
|
800 seasonal flu deaths a week 48% Canadians not keen on vaccine Death rate similar to seasonal Big drop in new swine flu cases Half of staff would refuse flu shot How safe is the swine flu vaccine? WHO says flu vaccines will be safe Alert must show 'actual' danger |
|
|
Oink is proving to be far worse WHO contradicts UK Tamiflu policy WHO predicts 'explosion' of cases Appoint swine flu health czar: CMAJ Vaccine linked to killer nerve disease Side-effects outweigh benefits Officials urge WHO to change alert Experts investigate flu evolved in lab |
Canadians 'having a nice quarantine' Report on China origin of swine flu |
|
Made by the giant Swiss-based pharmaceutical company Roche, Tamiflu was seen by some as a front-line defence in the H1N1 flu outbreak of 2009. The company has sold roughly $10B worth of Tamiflu in the 10 years since the drug was launched, much of that in the years surrounding the avian and H1N1 flu scares. IThese stockpiles came about largely on the recommendations of the Public Health Agency of Canada and its expert advisers, as well as some independent flu experts. (CBC) Drug ‘reports’ found to be faked |
Merck ruling 'huge' impact for Canada Brazil issues compulsory 'licence' Journal challenges Canadian led Vioxx study Merck denies holding back damning Vioxx info Merck & co. vows to appeal $253M judgment With Vioxx gone, now what do I do? Report: Vioxx linked to thousands of deaths 10 on panel had ties to companies Center for Science in the Public Interest Another shoe drops in faked studies Court told of plot to destroy drug critics Merck wins reversal of Vioxx ruling in Saskatchewan |
|
Canadian seniors are consuming a startling amount of prescription medications, says a new report, revealing almost two-thirds take 5 or more drugs a day and one-quarter take a whopping 10 or more. (Toronto Star) |
Not to be forgotten .pdf |
|
Superbugs kills 30,000 over 5 years LONDON - The number of people dying due to MRSA and Clostridium difficile fell sharply last year but the superbug infections were still responsible for 30,000 deaths in five years, figures show. (Times online) ONS |
VANCOUVER - Drug companies can do in Canada what they can’t in the US: advertise prescription drugs even if they carry risks for life-threatening complications, according to a UBC study. (Vancouver Sun) |
|
Drug industry at the crossroads WASHINGTON - Facing unprecedented pharmaceutical patent expirations over the coming years and subsequent competition with generic drug makers pharmaceutical companies are searching frantically for new cash cows or different business models to stabilize their businesses. (Epoch Times) PREVIOUS: Cardiovascular drug costs triple Long-term trends in use and expenditures for cardiovascular medications in Canada |
OTTAWA - Health Canada is getting tough with patients who use government-certified medical marijuana, demanding full payment in advance before shipping the weed. Previously, users could order and pay later. But hundreds of patients - who are often seriously ill, unable to work and on welfare or disability pensions - could not keep up with their Health Canada bills and built up large debts. (CTV) |
|
The PEI Pharmacy Board is looking for help from the public to find out if some pharmacies on the Island are selling for full price drugs that were provided as samples to doctors. The doctors get the samples for free from drug companies. (CBC) RELATED: New deal gives ON MDs 12% pay increase |
Proposals set to rile legal drug industry TORONTO - A new war is brewing over Canada's multi-billion-dollar prescription-drug business, fuelling death threats against a top government official, plans for a major lobbying campaign and predictions of furious political debate to come. (National Post) PREVIOUS: Taxpayers on the hook Tax hikes loom |
|
Technology could change health care Advances in health care run the gamut from mind-boggling medicines to simple web solutions that, if adopted, could slice huge slabs of fat from a bloated system. Whatever form innovation takes in the coming years, much of it will spring from start-ups, not pharma and tech giants. (Forbes) |
OTTAWA - A federal Conservative MP whose 15-year-old daughter collapsed and died after taking a prescription medication will this week introduce a private member's motion calling for an arm's length drug safety agency. (CBC) MORE: Loophole in unapproved drugs process Death by Prescription |
|
ST. JOHN’S - A scathing report has found that few of the people who die in Newfoundland and Labrador have access to appropriate palliative care, and spend their final days in needless anguish. (CBC) REPORT: Needs assessment of palliative care .pdf |
Andrew Wakefield, the doctor who sparked the scare over the safety of the MMR vaccine for children changed and misreported results in his research, creating the appearance of a possible link with autism. (Times online) PREVIOUS: MMR vaccine controversy |
|
Canadians still waiting too long Canadians are waiting less long for surgery, but are still experiencing delays of more than 17 weeks for treatment, according to new research published by the Fraser Institute. (Vancouver Province) MORE: Waiting your turn CHC blames wait lists on private clinics |
UnitedHealth settles cheating claims UnitedHealth Group Inc., the biggest US health insurer, said it will spend $400 million to settle allegations it has manipulated payments to doctors and patients for the last 15 years. (Bloomberg) MORE: Insurer will pay over 'rigged' information |
|
US bans key Indian drug imports WASHINGTON - The United States Food and Drug Administration (FDA) says it has banned the import of more than 30 generic drugs made by Indian drug firm Ranbaxy. (BBC) PREVIOUS: Ranbaxy Canada FDA defends plastic linked with health risks Common plastics chemical linked to human diseases Medical experts fight drug industry influence |
Dr. Allen Frances had calculated that the recommendations contained within the first draft for the fifth and latest revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM5) could unnecessarily trigger wholesale "epidemics" of mental illness. (CanWest) PREVIOUS: Psychiatry manual's secrecy criticized DSM |
|
Cheap air travel 'is spreading deadly diseases' UN - People are at greater risk of contracting potentially lethal infectious diseases because of the boom in international air travel, the World Health Organisation (WHO) has warned. (Telegraph UK) MORE: WHO predicts more global epidemics |
EU broadens inquiry BRUSSELS - European antitrust investigators are expanding the scope of a major inquiry into the $942B pharmaceutical market in a bid to determine whether companies are blocking generics makers from getting less-expensive medicines to market quickly. MORE: Pharmaceuticals sector inquiry |
|
NEW YORK - Direct-to-consumer (DTC) advertising has only a modest effect on the sale of drugs, according to research released online by BMJ, a British medical journal. (Washington Post) RELATED: Outsourcing the Drug Industry |
WASHINGTON - The chorus of consumer complaints about the drug, Chantix (Champix in Canada) is getting louder and louder. (Injury Board) PREVIOUS: Safety signal seen for Varenicline risks Champix wins Health Canada approval |
|
VANCOUVER – 12% of patients who rush to the emergency room at Vancouver General Hospital are there because of adverse effects from medications, according to study findings being published Tuesday in the Canadian Medical Association Journal. (Vancouver Sun) PREVIOUS: Drug errors hurt 1 in 15 More profit than progress in research Your kid's drug source |
ATLANTA - A prominent Emory University psychiatrist received at least $2.8 million in consulting fees from companies whose drugs he was evaluating and failed to report a third of it, congressional investigators studying medical conflicts of interest said. (Los Angeles Times) MORE: Psychiatrist failed to report $1.2M Charles B. Nemeroff |
|
NEW YORK - In western Virginia, far from the limelight, US Attorney John L. Brownlee found himself on the telephone last year with a political and legal superstar, Rudolph W. Giuliani. For years, Mr. Brownlee and his small team had been building a case that the maker of the painkiller OxyContin had misled the public when it claimed the drug was less prone to abuse than competing narcotics. (NY Times) |
THUNDER BAY - The local health unit warned today of a possible streptococcal disease outbreak in the city that has already killed 10 people. The Thunder Bay District Health Unit is investigating an outbreak of invasive Group A streptococcal infection. Since August 2007, there have been 75 cases in Thunder Bay and District. (Thunder Bay Source) MORE: Strep outbreak kept secret Strep outbreak likely to spread |
|
Widespread off-label drug prescription Thousands of times a day in Canada, patients are prescribed drugs “off-label,” meaning for conditions for which they have never been approved. (CanWest) |
Fentanyl pain patches recalled OTTAWA - In the latest of several alerts on the safety of fentanyl pain-relief patches, Health Canada has announced the recall of two brands of the powerful patches. (CTV) |
|
Health care lags far behind Europe TORONTO - Universal health care is something many Canadians cherish and want to fiercely protect, but a new study finds it lags far behind the standard of care that is commonplace in Western Europe. (CP) |
Euro-Canada Health Consumer Index 2008 |
|
Harmful drugs in St Lawrence River Montreal's waste-water treatment plant in Rivière des Prairies is treating an average of 32 square metres of waste water a second before releasing it into the St. Lawrence River. (Montreal Gazette) |
Factories dumping drugs into sewage |
|
Few doctors use electronic records because of costs BOSTON - Electronic health records (EHR), touted by the government as a way to reduce medical costs, are used by few doctors in the US because they are too expensive for their practices, a Harvard University survey found. The poll, published in the New England Journal of Medicine, found that just 4% of doctors use software that includes electronic prescriptions and drug-interaction warnings. (Bloomberg) EHR priority for Canada |
Currently, continuing medical education activities are, for the most part, sponsored by the pharmaceutical industry, which has a vested interest in promoting its products. This is big business: of the $2.6B spent in the US on accredited continuing medical education activities in 2006, $1.45B (60%) came from pharmaceutical and medical device manufacturers. (CMA Journal) PREVIOUS: CMA Journal takes on drug firms Global Pharmaceutical market $643B in 2006 |
|
Report faults FDA on trial audits WASHINGTON - The Food and Drug Administration does very little to ensure the safety of the millions of people who participate in clinical trials, a federal investigator has found. In a report released Daniel R. Levinson, said federal health officials do not know how many clinical trials are being conducted, audit less than 1% of the nation's testing sites, and, on the rare occasions when inspectors do appear, generally show up long after the tests are completed. (NY Times) |
FDA’s oversight of investigators’ financial information .pdf FDA may miss researchers' financial conflicts |
|
More than one in four Canadian seniors are still taking medications that are potentially harmful for their age group, finds a study released today by the Canadian Institute for Health Information. (CTV) STUDY: Drug claims by seniors: 2000-2006 More bad news for diabetes drug |
LONDON - Work really can kill you, according to a study on Wednesday providing the strongest evidence yet of how on-the-job stress raises the risk of heart disease by disrupting the body's internal systems. (Reuters) PREVIOUS: Whitehall II Miscarriage risk with 2 coffees a day |
|
Judge throws out price-fixing case LONDON - The criminal prosecution against Goldshield and four other drug companies over allegations they conspired to overcharge the NHS for generic medicines was part of the largest case ever launched by the agency. Judge Pitchford made an order banning the reporting of his reasons for rejecting the SFO's case. (Times online) |
Drug giants accused over doctors' perks NHS pays too much for its drugs 5 companies in NHS price fixing row |
|
A cancer vaccine with political will or powerful lobbying It has been called "the medical breakthrough of the 21st century" and the most significant development in women's reproductive health since the Pill. (National Post) PREVIOUS: Gardasil Merck & Co. Cervarix GlaxoSmithKline |
'Bio-Identical' hormone claims unsupported WASHINGTON - US health officials warned seven pharmacy operators on Wednesday that their claims about the safety and effectiveness of "'bio-identical" hormones were false, misleading and not supported by medical evidence. (Reuters) |
|
Doctors rely too heavily on drug company data: CMA Most of the information doctors receive about prescription drugs comes from the very companies making the product, a doctor said Wednesday, pointing to a possible reason why doctors continue to prescribe dangerous drugs to seniors. (CBC) PREVIOUS: Drugs continue to be prescribed Off Limits |
MONTREAL - Less than two months after quitting politics, Quebec's former health minister Philippe Couillard accepted a lucrative private-sector job that trumpets the future of private health care. Couillard was recruited as a partner at Persistence Capital Partners, Canada's first private equity fund that invests in health care businesses. (Montreal Gazette) |
|
MONTREAL - Some call it errors in billing; others say it's double-dipping. Under whatever label, the Quebec health insurance board recovers an estimated $2M annually from doctors found to have overbilled the system. But some hospital staff say it goes way beyond that. They say physicians are routinely invoicing for tens of thousands of dollars for services not rendered -"visiting" patients in hospital beds, for example. (Gazette) |
Cash-for-care allegations mount Ambulance bill waived for couple Drug firms' influence raises concerns |
|
MYRTLE BEACH, SC - People in the US are living in a world of pain and they are popping pills at an alarming rate to cope with it. The amount of five major painkillers sold at retail establishments rose 90 percent between 1997 and 2005, according to an Associated Press analysis of statistics from the DEA. (AP) |
A quarter of a century after the outbreak of AIDS, the World Health Organization (WHO) has accepted that the threat of a global heterosexual pandemic has disappeared. (Independent UK) REPORT: World health statistics 2008 WHO's department of HIV/Aids HIV patients live years after diagnosis |
|
REGINA - The West Nile virus has killed an elderly woman in the Regina Qu'Appelle Health Region and, as health officials predicted last week, the number of cases this year has reached a record high. (Regina Leader-Post) PREVIOUS: Canada invests $199M in flu vaccine GlaxoSmithKline |
A year after Ontario introduced new legislation that promised to make drug approvals more transparent, key parts of that legislation have still not been implemented. (Ottawa Citizen) PREVIOUS: Statistics Canada: Deaths by selected grouped causes List of causes of death by rate |
|
OTTAWA - Health Canada is trying to halt the sale and use of Resolve, a product used to help quit smoking, because of a potential health risk to consumers. (CanWest) MORE: Smoking cessation product is risky |
Avandia raises heart-death risk CHICAGO - Avandia, GlaxoSmithKline Plc's widely used drug for treating type 2 diabetes, increased the risk of heart death by 64% and the risk of heart attack by 43%, US researchers said. (Reuters) GSK knew of risks Glaxo settles Paxil lawsuit |
|
Free trade zones ease passage DUBAI, UAE - Three months ago, when the authorities announced that they had seized a large cache of counterfeit drugs from Euro Gulf's warehouse deep inside a sprawling free trade zone here, they gave no hint of the raid's global significance. |
Chinese gangs 'behind fake drugs' |
|
MONTREAL - Relatives of patients who either were infected or died from C. difficile diarrhea during an outbreak at a St. Hyacinthe hospital in 2006 have launched a class action against the local health authority for up to $10M in damages. (Gazette) |
|
|
The American Academy of Pediatrics (AAP) released updated guidelines for treating attention-deficit/hyperactivity disorder at its annual conference this weekend that expand the ages for the diagnosis and treatment of ADHD to preschoolers. (PostMedia) |
|
|
WASHINGTON - Four out of five doctors surveyed in the United States said they let drug and device makers buy them food and drinks despite recent efforts to tighten ethics rules and avoid conflicts of interest. (AP) PREVIOUS: National survey of physician-industry relationships Characteristics and Impact of Drug Detailing The drug pushers Big business behind your doctor's diagnosis |
Free drug samples go to wealthy WASHINGTON - The pharmaceutical industry contends that the samples help the uninsured and people with low incomes, but the study of prescription use by nearly 33,000 US residents during 2003 found that the neediest were least likely to get samples. (Reuters) PREVIOUS: Characteristics of recipients of free prescription drug samples The Cost of pushing pills |
|
US drug company to move trials to Canada MONTREAL - SFBC International, a controversial drug development company under Senate investigation in the United States says it will close its beleaguered Florida labs and transfer planned clinical trials to Canada. (CTV) PREVIOUS: Big Pharma's shameful secret |
AIDS drugs fiasco a tale of red tape As Canadian officials bickered about why Canada's Access to Medicines Regime failed to send one generic AIDS pill to needy countries, thousands of people died of the disease in Rwanda. (Toronto Star) PREVIOUS: US super market to offer free antibiotics Rwanda launches key test |
|
RENO, Nev. - A jury levied a $134.5M judgment against pharmaceutical giant Wyeth in a lawsuit filed by three Nevada women who claimed the company's hormone replacement drugs caused their breast cancer. (AP) Warning issued over drug Venlafaxine Wyeth Popular painkillers can raise heart risk |
FBI raids office of Bristol-Myers CEO NEW YORK - Agents for the Federal Bureau of Investigation raided the office of Bristol-Myers Squibb Co. Chief Executive Peter Dolan as part of a criminal antitrust probe, The Wall Street Journal reported. (Reuters) Drugmaker to pay SEC $150M
|
|
No 'rational discussion' at AIDS conference ANTIGONISH, NS - The federal minister of health says he didn't make funding or policy announcements at the International AIDS Conference because overwrought delegates were making it impossible to have a "rational discussion." (CP) |
AIDS cases drop, but due to revised data Suit over Aids drug price hike |
|
In the almost two decades since Prozac - the first of the antidepressants known as SRIs, or serotonin reuptake inhibitors — hit the market, many patients have reported extreme reactions to discontinuing the drugs. (AP) |
Spending to death: How much is living worth? Dying of lung cancer, Carolyn Hobbs tried a new biotechnology drug that produced an unanticipated side effect: acute sticker shock. (AP) |
|
Study: Teens use medicines to get high WASHINGTON - Teens increasingly are getting high with legal drugs like painkillers and mood stimulants, and they're turning to cough syrup as well, says a government survey. (AP) |
NIDA: Decrease in illicit drug use Teen prescription drug abuse 'entrenched' Partnership attitude study (PATS) 2005 Teen develops way to detect disease in body |
|
MANILA - Use of existing, low-cost tools and knowledge could save more than 6 million of the 9.7 million children who die yearly from easily preventable or curable causes, the report said. They include antibiotics that cost less than $0.30 to treat pneumonia and oral rehydration therapy (cost about $0.10) for diarrhea. (AP) |
Annual Report 2007 .pdf State of the World's Mothers 2008 .pdf 18,000 kids dies each day from hunger: UN Lack of sanitation kills millions every year |
|
Antidepressants linked to suicide TORONTO - Elderly people who take a popular type of antidepressants are almost five times more likely to commit suicide than those on other antidepressants, concludes a major new Canadian study that adds to the controversy around the drugs known as SSRIs. (CanWest) |
Institute for Clinical Evaluative Sciences (ICES) |
|
WASHINGTON - About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency's monitoring of the safety of prescription drugs now being sold, according to an FDA internal survey. (CBS) |
Claritin maker coughs up $346M A Review of 2004's drug controversies FDA 'incapable of protecting America' |
|
Petitions to FDA delay generic drugs When its hot-selling antidepressant Wellbutrin XL was facing the prospect of competition from cheaper generics late last year, Biovail Corp. filed a "citizen petition" with the FDA, raising concerns about the safety of its potential rivals. (Washington Post) RELATED: The lawlessness of the FDA |
Drug firms' research spending falls short OTTAWA - Brand-name drug makers spent $1.2B or 8.7% of their sales on research and development, marking the fifth consecutive year that the industry has failed to meet the 10-per-cent-of-sales ratio pledged when patent rules were strengthened in 1987. (Citizen) |
|
TORONTO - Health-care costs in Canada doubled over the past decade and will cross the $200B mark this year, a report released Thursday reveals. The report shows, though, that the growth in health-care spending has actually started to slow, after rising at an average of 7% a year during the period from 1998 to 2008. (CP) Health spending to reach $200B in 2011 |
Key players to boost generic drug profits Canadians still paying too much Drug prices in Canada & the US 2008 Canadians still getting gouged Canada's drug price paradox 2008 Drug firms' sway over Task Force |
|
Canadians spent $30B on legal drugs 2008 Canadians still paying too much Canada’s Drug Price Paradox 2010. Generic drug pricing and access Spending outpacing provincial revenue Health care spending to hit $183B |
We have to overcharge or we can't compete Ontario's 25% makes 50% look bad Ontario's ruinous Medicare habit Drug spending estimated at $30B in 2008 Drug costs have ballooned in Quebec Government doesn't mean cheaper drugs Affordability of drug spending 2010 Health care transformation in Canada .pdf Canada health consumer index 2010 .pdf Part 1: Cost of Cancer drugs .pdf |
|
CGPA Agency eyeing drug prices Health care spending to reach $148B Hospital responses to babies' deaths Health-care spending on the rise Use of cannabis and other illicit drugs |
Canadian Institute for Health Information Rebates keep generic drugs pricey Comparison of prescription drug plans Access to drugs is a 'postal cored lottery' Health authority reviews 15,000 reports Health Canada uses disputed research Medical researchers caught faking it Canadians not winners in generic drug wars Graduated drug licensing proposed Patients are 'revenue sources' |
|
Generic drug firms to fight new rules Questions loom over 'similar' deaths Provincial expected to spend $96B on health Health spending continues to rise Drug companies to tone down rhetoric Family income and the well-being of children Canada spends more on drugs, finds survey Canada has four-tier health care SC strikes down Que medicare law Province $5.5 M to enforce smoke-free plan |
Heart disease, cancer the top killers Quebec won't shelve health report Norovirus spreading in Winnipeg Medicines sending thousands to hospital Court rules Ontario can't be sued Drug Expenditure in Canada 1985 - 2005 Canadian Institute for Health Information Ruling rattles Canada Health Care Prescription drug spending in Canada Drug spending in Canada still on the rise, public sector's share increasing |
|
Canadian drugmaker labelled a bio-pirate in study UN - The Canadian maker of a supposed natural treatment for impotence is branded a suspected "bio-pirate" by US and South African environmental groups in a new study. (CanWest) STUDY: Out of Africa: Mysteries of Access and Benefit Sharing .pdf |
LONDON - Drug companies with "innovative" medicines would be able to bypass current safeguards and sell to the NHS at a high price under a fast-track procedure to be proposed by the Office for Life Sciences (OLS). (Guardian UK) PREVIOUS: How Drayson fattened up his drug firm on the taxpayer NICE |
|
Private health firm built on tax dollars TORONTO - As politicians here debate the private sector's role in health care, InterHealth Canada, a Canadian company with ties to provincial governments, public hospitals and universities is opening and operating new private medical facilities in Britain and the Persian Gulf. (National Post) |
Health fraud's new frontiers: Part 1 Health fraud's new frontiers: Part 2 Part 3 is subscription |
|
Ontario health care: 5 part series ONTARIO - Lengthy wait times, pervasive doctor shortages and medical errors are among the major health problems ailing Ontario’s system. Health care management in Ontario is perhaps 10 to 20 years behind the rest of Canada. At least one expert says the lag is costing money and lives. (Osprey Media Special Report) |
Rejection rates trigger state investigation SACRAMENTO - California AG Jerry Brown is joining state regulators in scrutinizing how HMOs review and pay insurance claims submitted by doctors, hospitals and other medical providers. (LA Times) MORE: Lobbyists target returning Congress Hospitals price gouging uninsured $1,133 hospital bill to clip toenail prompts suit |
|
NEW YORK - Pfizer Inc said it completed its $2.3B legal settlement with the government over marketing of its recalled Bextra painkiller and three other medicines, the largest in the US for claims of off-label drug promotion. (Bloomberg) Pfizer drafting customers to lobby |
Pfizer quarterly profit tripled AIDS group sues Pfizer over Viagra ads Pfizer faulted over drug trials in Nigeria Pfizer withdraws Bextra from market Illegal drug marketing admitted Pfizer: Celebrex poses heart risk |
|
20% of human genes have been patented in US A new study shows that 20% of human genes have been patented in the US, primarily by private firms and universities. (National Geographic) |
Most OTC cough syrups don't work Most over-the-counter cough syrups don't work, according to guidelines released from the American College of Chest Physicians. (Forbes) |
|
The study reported about 6% of the 3,000 junior high and high school students surveyed said they used prescription drugs such as OxyContin, Percocet and Tylenol 3. (CBC) |
2007 student drug use and health survey |
|
In response to growing criticism, the National Institutes for Health is set to ban its research scientists from accepting consulting deals and any other form of income from drug companies. (CBS) |
Researchers mum on financial interests |
|
It was a pleasant, informative break from the grind for a crowd of local doctors: lunch and a series of lectures at Vancouver’s chic Four Seasons Hotel, all presented free by Purdue Pharma, which had just rolled out a new pain drug called OxyContin. (National Post) Painkiller abuse reaches 'epidemic' level |
|
|
So many Canadian children are taking the drugs known as atypical antipsychotics that doctors are being asked to watch for major complications - including dramatic weight gain, tremors, and abnormal face and jaw movements. (PostMedia) |
Meds cause personality changes Personality change during treatment Pain relievers linked to more deaths FDA may call for stronger antidepressant warning Clinical drug trials 'distorted' |
|
Medical bills make up half of bankruptcies Costly illnesses trigger about half of all personal bankruptcies, and most of those who go bankrupt because of medical problems have health insurance, according to findings from a Harvard University study. (MSNBC) |
Pharmacies suffer drug shortages Medicare Rx cost estimate zooms Drugstores sue makers over prices Drug costs soar before 'discount' AARP Watchdog Report: Drug prices Drug prices outpacing inflation Medicare discount cards from Hell |
|
Drug Industry employs 675 Washington Lobbyists WASHINGTON DC - Public Citizen found that the drug industry hired 675 different lobbyists from 138 firms in 2002 – nearly seven lobbyists for each U.S. senator, according to federal lobbying disclosure records. The industry spent a record $91.4 million on lobbying activities in 2002, an 11.6 percent increase from 2001. Full Public Citizen Report .pdf Public Citizen |
|
|
Note: Mitch Daniels, Bush’s director of the office of management and budget, is a former executive at the pharmaceutical giant Eli Lilly. Whether or not prescription drug coverage can added to Medicare depends on whether there’s money in the federal budget to pay for it. And the man in charge of budgeting the money for the benefit - and determining if there’s a need for price controls is Mitch Daniels. |
|
|
Money paid by the Pharmaceuticals/Health Products industry 2004 Pharmaceutical companies have enjoyed unprecedented increases in profits over the last ten years, with drugs like Viagra and Prozac becoming household names. And, as profits went up, so did the industry’s campaign contributions. The pharmaceutical and health products companies industry, which includes not only drug manufacturers, but also dealers of medical products, and nutritional and dietary supplements, is consistently one of the top 20 industries for campaign contributions. The industry now gives eight times what it did in 1990. (Center for Responsive Politics) |
|
|
There is also the matter of rebates and supplemental rebates drug companies pay to state public aid departments for permission to sell drugs to Medicaid beneficiaries. Which creates a condition of state governments wanting the money on one hand while trying to keep its citizens happen by fighting for lower prices on the other. This is not unlike the Pension funds which invest funds in the Pharmaceutical companies because of their high profitability while at the same time being pressured by the Pension members who need a higher return on their pension because they have to pay so much for drugs. Nice cause and effect loops. All of this of course doesn't take into account any of the politics that are going on between the two US parties. |
|
|
One of the current arguments is that price regulation would stop or slow the development of new drugs. This appears to be a spin-doctor’s wish as the extensive tax credits to offset research and development costs are too important to the bottom line. The US government also spends about $23 billion a year on biomedical research though the National Institutes of Health, most of which passes through the NIH to contractors, universities and research institutions. National Institutes of Health |
|
|
Drug Companies spend almost 2 1/2 more on marketing and administration as on R&D WASHINGTON - U.S. drug companies that market the 50 most often prescribed drugs to seniors spent almost two-and-one-half times as much on marketing, advertising, and administration as they spent on research and development. Research spending 2nd to marketing |
Company - Percent of Revenues Spent on Marketing/ Advertising/ Administration Abbott Laboratories 23% Allergan 42% Merck 13% Pfizer 35% Schering-Plough 36% Wyeth 37% According to Public Citizen, an advocacy group, the industry's advertising costs rose from $791 million in 1996 to $2.5 billion in 2001. |
|
Canadian Council of Better Business Bureaus Consumer: |
|
|
|
|
|
Follow the Money. The Pharmaceutical Industry: The Other Drug Cartel .pdf |
|
|
America's Other Drug Problem: A Briefing Book on the Rx Drug Debate .pdf |
|
| Recent Headlines | |